David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
W.W. Grainger
GWW
$62.3B
| $257K | ﹤0.01% |
+1,103
| New | +$231K |
|
3052
Black Hills Corp
BKH
$5.49B
| $256K | ﹤0.01% |
4,250
-23,261
| -85% | -$1.24M |
|
3053
Polaris
PII
$3.66B
| $256K | ﹤0.01% |
2,603
-20,879
| -89% | -$1.81M |
|
|
GBT
3054
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $256K | ﹤0.01% |
+16,142
| New | +$287K |
|
|
GMLP
3055
DELISTED
Golar LNG Partners LP
GMLP
| $256K | ﹤0.01% |
17,409
+300
| +2% | +$4.02K |
|
|
AXAS
3056
DELISTED
Abraxas Petroleum Corp
AXAS
| $256K | ﹤0.01% |
12,682
-12,954
| -51% | -$252K |
|
|
BKI
3057
DELISTED
Black Knight, Inc. Common Stock
BKI
| $254K | ﹤0.01% |
8,200
-497
| -6% | -$14.6K |
|
|
GK
3058
DELISTED
G&K Services Inc
GK
| $254K | ﹤0.01% |
3,472
-8,328
| -71% | -$543K |
|
3059
Jacobs Solutions
J
$17.7B
| $253K | ﹤0.01% |
+7,012
| New | +$229K |
|
|
ATCO
3060
DELISTED
Atlas Corp.
ATCO
| $253K | ﹤0.01% |
+13,818
| New | +$231K |
|
3061
AngloGold Ashanti
AU
$60.9B
| $252K | ﹤0.01% |
18,394
-29,457
| -62% | -$319K |
|
3062
PUT
3D Systems Corp
DDD
$518M
| $252K | ﹤0.01% |
16,300
-48,400
| -75% | -$499K |
|
|
TA
3063
DELISTED
TravelCenters of America LLC
TA
| $252K | ﹤0.01% |
7,445
+2,480
| +50% | +$96K |
|
3064
Integer Holdings
ITGR
$4.25B
| $251K | ﹤0.01% |
7,039
-4,255
| -38% | -$150K |
|
3065
Kodak
KODK
$948M
| $251K | ﹤0.01% |
23,100
-20,461
| -47% | -$200K |
|
|
GNBC
3066
DELISTED
Green Bancorp, Inc
GNBC
| $251K | ﹤0.01% |
+33,207
| New | +$260K |
|
3067
Akebia Therapeutics
AKBA
$250M
| $250K | ﹤0.01% |
+27,700
| New | +$225K |
|
3068
Gladstone Capital
GLAD
$448M
| $250K | ﹤0.01% |
16,768
-4,440
| -21% | -$58.4K |
|
|
WIN
3069
DELISTED
Windstream Holdings Inc
WIN
| $250K | ﹤0.01% |
6,522
-240,619
| -97% | -$7.81M |
|
3070
Camden National
CAC
$961M
| $249K | ﹤0.01% |
8,888
-2,349
| -21% | -$63.2K |
|
3071
PUT
Rithm Capital
RITM
$5.72B
| $249K | ﹤0.01% |
21,400
| – | – |
|
|
BBL
3072
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $249K | ﹤0.01% |
10,940
-15,149
| -58% | -$317K |
|
|
MSB
3073
Mesabi Trust
MSB
$305M
| $247K | ﹤0.01% |
41,195
-3,710
| -8% | -$18.1K |
|
3074
Rockwell Automation
ROK
$47.7B
| $247K | ﹤0.01% |
2,172
-37,599
| -95% | -$3.81M |
|
3075
PUT
Teck Resources
TECK
$34.4B
| $247K | ﹤0.01% |
32,500
-27,300
| -46% | -$148K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.